Skip to main navigation Skip to search Skip to main content

IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo

  • Laurence Zitvogel
  • , Bettina Couderc
  • , Jose I. Mayordomo
  • , Paul D. Robbins
  • , Michael T. Lotze
  • , Walter J. Storkus

Research output: Contribution to journal › Article › peer-review

84   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science